ReviewCureus2022
Human Papillomavirus Prevention by Vaccination: A Review Article.
Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025.Human vaccines & immunotherapeutics · 2026Article
- A guide to healthcare maintenance for the patient with inflammatory bowel disease.Annals of gastroenterology · 2026Review
- Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake.Frontiers in public health · 2025Article
- Benign tumors broaden the field of application for immunotherapy.Frontiers in immunology · 2025Review
- Article
- Influence of Knowledge and Cultural Beliefs on Attitudes Toward HPV Vaccination Among Israeli Nurses and Nursing Students: Implications for Vaccine Advocacy.Nursing reports (Pavia, Italy) · 2024Article
- Impact of Ascending HPV Infection on Colorectal Cancer Risk: Evidence from a Nationwide Study.Microorganisms · 2024Article
- Article
- Article
- Review
- Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study.PloS one · 2024Article
- A CRR2-Dependent sRNA Sequence Supports Papillomavirus Vaccine Expression in Tobacco Chloroplasts.Metabolites · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is the most common cancer among women worldwide. It is caused by infection due to human papillomavirus. There are some screening tests available for its detection. Early detection can increase the chances of survival. The HPV vaccine offers a long-lasting, reliable defence against the HPV infection that is most frequently linked to cancer. HPV 16 and HPV18 are high-risk cancer-causing strains. It is transmitted most commonly through the sexual route. There are horizontal and vertical modes of transmission of the infection present. Vaccines have been introduced to prevent cervical cancer in the market. Awareness and knowledge of vaccines are lacking in people. Vaccine awareness can be made in schools, colleges or among their parents. Social media is vital in spreading knowledge faster in today's generation. The number of precancers of the cervix in young women has been reduced due to HPV vaccination. A practical and safe method to prevent HPV is early vaccination. Vaccines provide cell-mediated immunity. It is more helpful if the vaccine is taken at a younger age. It can only prevent, not treat, cervical cancer. General practitioners are essential in informing people of the vaccine and its potential benefits. There are many ongoing types of research going on in this field so that people can get relevant information. The objective of this review is to provide information about the research till now, knowledge among people, the need for vaccines, effects and safety of vaccination. Research is going around the world to prevent cancer, which can decrease the worldwide burden of deaths due to cancer. Among all types of cancer, vaccines are available only for preventing cervical cancer, which has a high prevention rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.